obesonuqa.wordpress.com
Genzyme (NASDAQ: GENZ) founde a virus strain and stoppedr production of two drugs atthe Allston, facility. The strain, Vesivirus 2117, apparentlyu does not cause human infectionb but interrupts the growth of cells that are used to make Aldurazyme — a treatment for MPS I, a rare and fatalo disease caused by an enzyme deficiency was last filled at the Genzyms facility in September 2008, according to BioMarin (NASDAQ: The company has about 10 months of viale d inventory on hand, it said, and uses a secondf fill finish supplier. A third supplier is expected to be qualifieed laterthis year, BioMarin said. BioMarin make s the bulk material used in Aldurazyme at itsNovatl facility.
The Food and Drug Administratio n hadinspected Genzyme’s plant in September and October and reportedly was concerneds about controls to protectt against contamination.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment